£16.0M
The investment will fund UK commercial rollout and US regulatory approval for the company's remote patient monitoring platform.
Entia
Entia develops remote patient monitoring and blood testing technology for cancer treatment.
£24.8MTotal raised
Entia develops remote patient monitoring technology and predictive analytics to support individuals undergoing cancer treatment. The company combines at-home blood testing with digital solutions to provide personalised health insights.
Filed accounts
Cash at bank
Members only
Net current assets
Members only
Total assets less current liabilities
Members only
Net assets
Members only
Shareholders' funds
Members only
Fixed assets
Members only
Cash, assets and headcount from Entia's latest Companies House filing — with year-on-year movement, free with a Winfred account.
Categories
Founders
TB
Toby Basey-Fisher
CEO and Founder
Investors
- £16.0M
- £8.8M
Funding history
£8.8M
The investment round was led by BGF with participation from Parkwalk and Sussex Place Ventures.